Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects

Journal of Psychopharmacology May 3, 2023 DOI: 10.1177/02698811231169641 via OpenAlex

Summary

AI-generated from the abstract

The text is too brief to summarize. It only indicates the intended audience is international, without providing any substantive content, finding, argument, or description.

Study at a glance

Characteristics	Peer reviewed
Citations	1

Abstract

International audience

Reply to: Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects Journal of Psychopharmacology July 1, 2023 via Semantic Scholar
Amanita muscaria in the evolving novel psychoactive substances landscape - toxicological risks and clinical implications: a narrative review Frontiers in Pharmacology May 26, 2026 via OpenAlex
Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use Journal of Psychopharmacology July 17, 2020 33 citations via OpenAlex
Mushroom bioactives—polysaccharides to psilocybin: a viewpoint on the therapeutic use of mushrooms for consumers and patients for health and neuroplasticity Translational Food Sciences January 1, 2025 3 citations via OpenAlex
The Return of Psychedelics: Still Time to Prevent Tragedy Psychiatric News March 31, 2021 1 citation via OpenAlex

Comments

No comments yet.

Summary

Study at a glance

Abstract

Related reading

Comments